FDP
INDV icon

Financiere des Professionnels’s Indivior Pharmaceuticals INDV Stock Holding History

Financiere des Professionnels’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$363K Hold
11,917
– – 0.02% 259
2025
Q4 		$428K Buy
11,917
+2,502
+27% +$76.4K 0.02% 232
2025
Q3 		$227K Buy
+9,415
New +$197K 0.01% 313

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Financiere des Professionnels's INDV Position: Q1 2026 in Review

Financiere des Professionnels held its Indivior Pharmaceuticals (INDV) position steady in Q1 2026 at 11,917 shares worth $363K. The position accounts for 0.02% of the portfolio, ranked #259.

Financiere des Professionnels first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. The position peaked at $428K in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Financiere des Professionnels held 11,917 shares of Indivior Pharmaceuticals worth $363K as of Q1 2026.
  • Financiere des Professionnels left its Indivior Pharmaceuticals share count unchanged in Q1 2026.
  • Indivior Pharmaceuticals made up 0.02% of Financiere des Professionnels's portfolio in Q1 2026, its #259 holding.
  • Financiere des Professionnels first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Financiere des Professionnels's Indivior Pharmaceuticals position peaked at $428K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Financiere des Professionnels's 13F filing for Q1 2026, filed 6 May 2026.